Prevalence and risk factors for depression in newly diagnosed patients with POEMS syndrome

References

• Kravitz RL, Ford DE. Introduction: chronic medical conditions and depression–the view from primary care. Am J Med 2008;121:S1–S7.
   PubMed Web of Science ®Google Scholar
• Iannone M, Pennick L, Tom A, et al. Prevalence of depression in adults with haemophilia. Haemophilia 2012;18:868–874.
   PubMed Web of Science ®Google Scholar
• Chapman DP, Perry GS, Strine TW. The vital link between chronic disease and depressive disorders. Prev Chronic Dis 2005;2:A14.
   PubMedGoogle Scholar
• Simon GE. Treating depression in patients with chronic disease: recognition and treatment are crucial; depression worsens the course of a chronic illness. West J Med 2001;175:292–293.
   PubMedGoogle Scholar
• Cooke L, Gemmill R, Kravits K, et al. Psychological issues of stem cell transplant. Semin Oncol Nurs 2009;25:139–150.
   PubMedGoogle Scholar
• Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496–2506.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang W, Jiao L, et al. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 2011;117:6445–6449.
   PubMed Web of Science ®Google Scholar
• Sójka M, Gajos A, Pigońska J, et al. Guillain-Barré syndrome as the first manifestation of POEMS syndrome. Neurol Neurochir Pol 2012;46:284–287.
   PubMed Web of Science ®Google Scholar
• Unützer J, Katon W, Callahan CM, et al. Improving mood-promoting access to collaborative treatment. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002;288:2836–2845.
   PubMed Web of Science ®Google Scholar
• Hartl HK, Reitter S, Eidher U, et al. The impact of severe haemophilia on the social status and quality of life among Austrian haemophiliacs. Haemophilia 2008;14:703–708.
   PubMed Web of Science ®Google Scholar
• Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004;66:802–813.
   PubMed Web of Science ®Google Scholar
• Mols F, Husson O, Roukema JA, et al. Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry. J Cancer Surviv 2013;7:484–492.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–613.
   PubMed Web of Science ®Google Scholar
• Graham RC, Hughes RA. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 2006;77:973–976.
   PubMed Web of Science ®Google Scholar
• Li J, Zhou DB. New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol 2013;161:303–315.
   PubMed Web of Science ®Google Scholar
• Yu X, Tam WW, Wong PT, et al. The Patient Health Questionnaire-9 for measuring depressive symptoms among the general population in Hong Kong. Compr Psychiatry 2012;53:95–102.
   PubMed Web of Science ®Google Scholar
• Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768–1775.
   PubMed Web of Science ®Google Scholar
• Himelhoch S, Weller WE, Wu AW, et al. Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care 2004;42:512–521.
   PubMed Web of Science ®Google Scholar
• Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology 2014;23:121–130.
   PubMed Web of Science ®Google Scholar
• Gu L, Xie J, Long J, et al. Epidemiology of major depressive disorder in mainland china: a systematic review. PLoS One 2013;8:e65356.
   PubMed Web of Science ®Google Scholar
• Vileikyte L, Peyrot M, Gonzalez JS, et al. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study. Diabetologia 2009;52:1265–1273.
   PubMed Web of Science ®Google Scholar
• Vileikyte L, Leventhal H, Gonzalez JS, et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care 2005;28:2378–2383.
   PubMed Web of Science ®Google Scholar
• Bailey R, Kaskutas V, Fox I, et al. Effect of upper extremity nerve damage on activity participation, pain, depression, and quality of life. J Hand Surg Am 2009;34:1682–1688.
   PubMed Web of Science ®Google Scholar
• Chen JF, Chen YC, Lee HS, et al. POEMS syndrome presenting as long-term refractory ascites. J Med Sci 2008;28:169–174.
   Google Scholar
• Mercier A, Auger-Aubin I, Lebeau JP, et al. Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Fam Pract 2013; 14:55.
   PubMed Web of Science ®Google Scholar
• Gherardi RK, Bélec L, Soubrier M, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood 1996;87:1458.
   PubMed Web of Science ®Google Scholar
• Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 1998; 21:1390.
   PubMed Web of Science ®Google Scholar
• Musselman DL, Miller AH, Porter MR, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001;158:1252–1257.
   PubMed Web of Science ®Google Scholar
• Clark-Raymond A, Halaris A. VEGF and depression: a comprehensive assessment of clinical data. J Psychiatr Res 2013;47:1080–1087.
   PubMed Web of Science ®Google Scholar
• Patten SB. Exogenous corticosteroids and major depression in the general population. J Psychosom Res 2000;49:447–449.
   PubMed Web of Science ®Google Scholar